Table 1 Study participant characteristics
All Patients (n = 72) | Recurrent Patients (n = 36) | Single episode Patients (n = 36) | P valuea | |
|---|---|---|---|---|
Age (y, median (IQR)) | 73.5 (64, 83.5) | 78 (68.25, 88.5) | 72 (60.5, 80) | 0.239 |
Race (%) | ||||
White | 36 (50.0) | 17 (47.2) | 19 (52.8) | 0.637 |
Black | 6 (8.3) | 4 (11.1) | 2 (5.6) | 0.674 |
Hispanic | 21 (29.2) | 13 (36.1) | 8 (22.2) | 0.195 |
Asian | 3 (4.2) | 0 | 3 (8.3) | 0.239 |
Other | 6 (8.3) | 2 (5.6) | 4 (11.1) | 0.674 |
UTI Diagnosis (%) | ||||
Urinary tract infection | 61 (84.7) | 31 (86.1) | 30 (83.3) | 0.743 |
Pyelonephritis | 6 (8.3) | 2 (5.6) | 4 (11.1) | 0.674 |
Urosepsis | 2 (2.8) | 1 (2.8) | 1 (2.8) | 1.000 |
Other | 3 (4.2) | 2 (5.6) | 1 (2.8) | 1.000 |
History of UTI (%) | 26 (36.1) | 26 (72.2) | N/A | |
No. of episodes w/in 12 mon (median (IQR)) | 1 (0, 3) | 3 (2, 4) | N/A | |
Comorbid Conditions (%) | ||||
Diabetes | 18 (25.0) | 12 (33.3) | 6 (16.7) | 0.173 |
Immunocompromised | 15 (20.8) | 6 (16.7) | 9 (25.0) | 0.563 |
Kidney Disease | 17 (23.6) | 11 (30.6) | 6 (16.7) | 0.267 |
Chronic foley catheter | 3 (4.2) | 3 (8.3) | 0 | 0.239 |
Dementia | 15 (20.8) | 9 (25.0) | 6 (16.7) | 0.563 |
Functional quadriplegia | 3 (4.2) | 1 (2.8) | 2 (5.6) | 1.000 |
Admission (%) | ||||
ED | 21 (29.1) | 9 (25.0) | 12 (33.3) | 0.605 |
Hospital | 48 (66.7) | 24 (66.7) | 24 (66.7) | 1.000 |
Other | 3 (4.2) | 3 (8.3) | 0 | 0.239 |
Discharge Disposition (%) | ||||
Home | 40 (55.6) | 19 (52.8) | 21 (58.3) | 0.635 |
Skilled nursing facility | 25 (34.7) | 14 (38.9) | 11 (30.6) | 0.458 |
Deceased | 3 (4.2) | 0 | 3 (8.3) | 0.239 |
Other | 4 (5.6) | 3 (8.3) | 1 (2.8) | 0.614 |
No. of Antibiotics Prescribed (median (IQR)) | 2 (1, 2) | 2 (1, 2) | 2 (1, 2) | |
Antibiotic prescribed (n (%)) | ||||
Ertapenem | 27 (37.5) | 15 (41.7) | 12 (33.3) | 0.627 |
Meropenem | 11 (15.3) | 5 (13.9) | 6 (16.7) | 0.865 |
Trimethoprim-Sulfamethoxazole | 7 (9.7) | 2 (5.6) | 5 (13.9) | 0.460 |
Nitrofurantoin | 16 (22.2) | 11 (30.6) | 5 (13.9) | 0.182 |
Fosfomycin | 1 (1.4) | 1 (2.8) | 0 | 0.532 |
Ciprofloxacin | 6 (8.3) | 2 (5.6) | 4 (11.1) | 0.643 |
Piperacillin-Tazobactam | 7 (9.7) | 3 (8.3) | 4 (11.1) | 0.842 |
Amoxicillin-Clavulanate | 2 (2.8) | 1 (2.8) | 1 (2.8) | 0.840 |
Cephalexin | 3 (4.2) | 2 (5.6) | 1 (2.8) | 0.742 |
Cefdinir | 1 (1.4) | 1 (2.8) | 0 | 0.532 |
Cefuroxime | 3 (4.2) | 2 (5.6) | 1 (2.8) | 0.742 |
Ceftriaxone | 24 (33.3) | 10 (27.8) | 14 (38.9) | 0.584 |
Gentamicin | 1 (1.4) | 0 | 1 (2.8) | 0.358 |